C. Modess

发表

CYP2D6 genotype and induction of intestinal drug transporters by rifampin predict presystemic clearance of carvedilol in healthy subjects

H. Kroemer, W. Weitschies, I. Cascorbi, 2004, Clinical pharmacology and therapeutics.

Metabolic activation and analgesic effect of flupirtine in healthy subjects, influence of the polymorphic NAT2, UGT1A1 and GSTP1.

Karen Methling, Christiane Modess, Werner Siegmund, 2015, British journal of clinical pharmacology.

Oral absorption of propiverine solution and of the immediate and extended release dosage forms: influence of regioselective intestinal elimination

S. Oswald, R. Oertel, W. Siegmund, 2008, European Journal of Clinical Pharmacology.

Pharmacokinetic Drug‐Drug Interactions Between Trospium Chloride and Ranitidine Substrates of Organic Cation Transporters in Healthy Human Subjects

M. Tzvetkov, M. Weiss, H. Schulz, 2019, Journal of clinical pharmacology.

Simvastatin does not influence the intestinal P-glycoprotein and MPR2, and the disposition of talinolol after chronic medication in healthy subjects genotyped for the ABCB1, ABCC2 and SLCO1B1 polymorphisms.

I. Cascorbi, W. Siegmund, S. Haenisch, 2006, British journal of clinical pharmacology.

Extended‐release but not immediate‐release and subcutaneous methylnaltrexone antagonizes the loperamide‐induced delay of whole‐gut transit time in healthy subjects

W. Weitschies, S. Oswald, W. Siegmund, 2016, Journal of clinical pharmacology.

Compartment‐Specific Gene Regulation of the CAR Inducer Efavirenz In Vivo

M. Nauck, H. Kroemer, C. Spielhagen, 2012, Clinical pharmacology and therapeutics.

Chiral Pharmacokinetics and Metabolite Profile of Prolonged-release Ketamine Tablets in Healthy Human Subjects

A. Link, W. Siegmund, M. Grube, 2021, Anesthesiology.

Anxiety sensitivity and expectation of arousal differentially affect the respiratory response to caffeine

A. Hamm, T. Blumenthal, K. Methling, 2015, Psychopharmacology.

Carbamazepine regulates intestinal P‐glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans

Michael Zschiesche, Markus Grube, Christiane Modess, 2004, Clinical pharmacology and therapeutics.

Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid-enhanced MR imaging.

N. Hosten, J. Kühn, W. Weitschies, 2012, Radiology.

Pharmacokinetic and Pharmacodynamic Interactions Between the Immunosuppressant Sirolimus and the Lipid‐Lowering Drug Ezetimibe in Healthy Volunteers

W. Weitschies, D. Lütjohann, S. Oswald, 2010, Clinical pharmacology and therapeutics.

Muscle Injury After Intramuscular Administration of Diclofenac: A Case Report Supported by Magnetic Resonance Imaging

N. Hosten, J. Kühn, W. Weitschies, 2017, Drug Safety - Case Reports.

Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well‐being and cognitive performance in hypothyroidism

M. Nauck, A. Weike, M. Nauck, 2004, Clinical endocrinology.

Resolving the physiological conditions in bioavailability and bioequivalence studies: Comparison of fasted and fed state.

M. Grimm, W. Weitschies, M. Koziolek, 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

The Talinolol Double-Peak Phenomenon Is Likely Caused by Presystemic Processing After Uptake from Gut Lumen

Michael Zschiesche, Werner Weitschies, Christiane Modess, 2005, Pharmaceutical Research.

Drug Interactions Between the Immunosuppressant Tacrolimus and the Cholesterol Absorption Inhibitor Ezetimibe in Healthy Volunteers

W. Weitschies, D. Lütjohann, S. Oswald, 2011, Clinical pharmacology and therapeutics.

Targeted adsorption of molecules in the colon with the novel adsorbent‐based Medicinal Product, DAV132: A proof of concept study in healthy subjects

J. de Gunzburg, W. Weitschies, A. Andremont, 2015, Journal of clinical pharmacology.

Trospium chloride is absorbed from two intestinal "absorption windows" with different permeability in healthy subjects.

W. Weitschies, M. Weiss, H. Schulz, 2016, International journal of pharmaceutics.

Effects of the P‐Glycoprotein Inhibitor Clarithromycin on the Pharmacokinetics of Intravenous and Oral Trospium Chloride: A 4‐Way Crossover Drug‐Drug Interaction Study in Healthy Subjects

M. Weiss, H. Schulz, W. Siegmund, 2019, Journal of clinical pharmacology.

Impact of Efavirenz on Intestinal Metabolism and Transport: Insights From an Interaction Study With Ezetimibe in Healthy Volunteers

J. Mostertz, D. Lütjohann, S. Oswald, 2012, Clinical pharmacology and therapeutics.

Propranolol selectively blocks the enhanced parietal old/new effect during long-term recollection of unpleasant pictures: A high density ERP study

Georg Engel, Mathias Weymar, Alfons O. Hamm, 2010, NeuroImage.

Metabolic activation and analgesic effect of flupirtine in healthy subjects, influence of the polymorphic NAT2, UGT1A1 and GSTP1.

D. Rosskopf, P. Bednarski, K. Methling, 2015, British journal of clinical pharmacology.

Extended‐release but not immediate‐release and subcutaneous methylnaltrexone antagonizes the loperamide‐induced delay of whole‐gut transit time in healthy subjects

W. Weitschies, S. Oswald, W. Siegmund, 2016, Journal of clinical pharmacology.